DE69731386D1 - Verfahren zur behandlung von asthma mit o-desulfatisiertem heparin - Google Patents

Verfahren zur behandlung von asthma mit o-desulfatisiertem heparin

Info

Publication number
DE69731386D1
DE69731386D1 DE69731386T DE69731386T DE69731386D1 DE 69731386 D1 DE69731386 D1 DE 69731386D1 DE 69731386 T DE69731386 T DE 69731386T DE 69731386 T DE69731386 T DE 69731386T DE 69731386 D1 DE69731386 D1 DE 69731386D1
Authority
DE
Germany
Prior art keywords
desulfated
heparine
treating asthma
reducing
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731386T
Other languages
English (en)
Other versions
DE69731386T2 (de
Inventor
P Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ParinGenix Inc
Original Assignee
ParinGenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ParinGenix Inc filed Critical ParinGenix Inc
Publication of DE69731386D1 publication Critical patent/DE69731386D1/de
Application granted granted Critical
Publication of DE69731386T2 publication Critical patent/DE69731386T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69731386T 1996-07-29 1997-07-03 Verfahren zur behandlung von asthma mit o-desulfatisiertem heparin Expired - Lifetime DE69731386T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2439196P 1996-07-29 1996-07-29
US24391P 1996-07-29
PCT/US1997/012419 WO1998004133A1 (en) 1996-07-29 1997-07-03 Methods of treating asthma with o-desulfated heparin

Publications (2)

Publication Number Publication Date
DE69731386D1 true DE69731386D1 (de) 2004-12-02
DE69731386T2 DE69731386T2 (de) 2006-02-16

Family

ID=21820348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731386T Expired - Lifetime DE69731386T2 (de) 1996-07-29 1997-07-03 Verfahren zur behandlung von asthma mit o-desulfatisiertem heparin

Country Status (9)

Country Link
US (1) US5990097A (de)
EP (1) EP0918461B1 (de)
JP (1) JP4097044B2 (de)
AT (1) ATE280496T1 (de)
AU (1) AU727352B2 (de)
CA (1) CA2261872C (de)
DE (1) DE69731386T2 (de)
ES (1) ES2231880T3 (de)
WO (1) WO1998004133A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1371666B1 (de) * 1994-07-01 2007-08-15 Seikagaku Corporation Verwendung von desulfatiertem Heparin
BR9806540C1 (pt) * 1998-06-09 2001-05-08 Akira Yoshitome Produto farmacêutico para tratamento de hemofilia e de bronquite asmática
NZ509271A (en) 1998-08-18 2003-10-31 Univ California Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
WO2000012726A2 (en) 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2370539C (en) 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
ES2527853T3 (es) * 2000-03-08 2015-01-30 Massachusetts Institute Of Technology Heparinasa III y sus usos
CA2423469A1 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
CA2483271A1 (en) * 2002-04-25 2003-11-06 Momenta Pharmaceuticals, Inc. Methods and products for mucosal delivery
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
US7468358B2 (en) * 2004-06-16 2008-12-23 Paringenix, Inc. Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome
US20050282775A1 (en) * 2004-06-16 2005-12-22 Paringenix, Inc. Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
WO2007019554A2 (en) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides for delivery of active agents
US20080207489A1 (en) * 2007-02-21 2008-08-28 John Castellot Use of CCN5 for treatment of smooth muscle proliferation disorders
CA2678587A1 (en) * 2007-02-28 2008-09-04 Paringenix, Inc. O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease
EP2170354A1 (de) * 2007-07-23 2010-04-07 University of Utah Research Foundation Verfahren zur blockierung der ligation des rezeptors für endprodukte fortgeschrittener glykierung (rage)
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) * 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (de) * 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Nicht gerinnungshemmende polysaccharidzusammensetzungen
WO2011060201A1 (en) * 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Methods and systems for screening subjects
WO2011130697A2 (en) 2010-04-16 2011-10-20 Momenta Pharmaceuticals, Inc. Tissue targeting
CN103096870B (zh) 2010-06-17 2017-04-19 动量制药公司 调节毛发生长的方法和组合物
TW201306847A (zh) * 2010-11-30 2013-02-16 Vectura Ltd 組成物及用途
SG10201603059YA (en) 2012-05-09 2016-05-30 Cantex Pharmaceuticals Inc Treatment Of Myelosuppression
CA2910837A1 (en) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
WO2015142924A1 (en) 2014-03-17 2015-09-24 Cantex Pharmaceuticals, Inc. Multivalent cation formulations of partially desulfated heparins
WO2016133910A1 (en) 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
WO1993019734A1 (en) * 1992-04-02 1993-10-14 Baker Norton Pharmaceuticals, Inc. Method and composition for treating antigen-induced and exercise-induced asthma
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby

Also Published As

Publication number Publication date
EP0918461A4 (de) 2002-11-13
EP0918461A1 (de) 1999-06-02
JP2001506673A (ja) 2001-05-22
WO1998004133A1 (en) 1998-02-05
JP4097044B2 (ja) 2008-06-04
US5990097A (en) 1999-11-23
ES2231880T3 (es) 2005-05-16
DE69731386T2 (de) 2006-02-16
AU727352B2 (en) 2000-12-14
CA2261872C (en) 2004-06-15
CA2261872A1 (en) 1998-02-05
EP0918461B1 (de) 2004-10-27
ATE280496T1 (de) 2004-11-15
AU3729997A (en) 1998-02-20

Similar Documents

Publication Publication Date Title
DE69731386D1 (de) Verfahren zur behandlung von asthma mit o-desulfatisiertem heparin
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
WO2000059487A3 (en) Flupirtine in the treatment of fibromyalgia and related conditions
DE69423061T2 (de) Gasturbinenschaufel, Verfahren zur Herstellung derselben sowie Gasturbine mit dieser Schaufel
DE69128073D1 (de) Verfahren zur herstellung von metalloxidaerogelen mit dichte weniger als 0,02 g/cm3
DE69523943T2 (de) Neue antithrombotische formulierung, verfahren zur herstellung und gebrauch davon
DE69526863D1 (de) Neue 1,2-dioxetane mit haloalkoxy-gruppen, verfahren zur herstellung und verwendung
DE69003152D1 (de) Verfahren und Vorrichtung zur kontinuierlichen Herstellung von mit fibrilliertem Polymer gebundenen Elektrodenkomponenten.
DE69012177D1 (de) Verfahren zur Herstellung von Halbprodukten mit Rundstrickmaschinen, insbesondere zur Herstellung von Unterhemden, Hemdhosen und dergleichen.
DE69115909T2 (de) Verwendung von Phospholipiden zur Herstellung eines topischen Arzneimittels zur Beinflussung des Serumcholesterinspiegels
DE3861018D1 (de) Mineralischer stoff, verfahren zu seiner herstellung und verwendung desselben.
DE69407419D1 (de) 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe
ATA191190A (de) Filter mit teilchenförmigem sorptionsmittel und verfahren zu seiner herstellung
DE3880763D1 (de) Im wesentlichen fluessigkeitsundurchlaessige polymere warenbahn mit mikroblaeschen und verfahren und vorrichtung fuer deren herstellung.
DE3888184D1 (de) Verfahren zur Herstellung von Masken mit Strukturen im Submikrometerbereich.
DE3881669D1 (de) Waermeresistenter verbundkoerper und verfahren zu seiner herstellung.
AU4626389A (en) Use of minoxidil for wound healing
DE3855699T2 (de) Verfahren zur Herstellung eines supraleitenden Gegenstandes sowie diesen Gegenstand verwendende Vorrichtung und Systeme
DE3863651D1 (de) Magnetischer russ, verfahren zu seiner herstellung und modifizierung von magnetischem russ.
GB2311636A (en) Method and structure for clustering database tables into classes and presenting each class as an E-R model
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
AT374846B (de) Herzstueck, insbesondere herzstueckspitze, fuer schienenkreuzungen oder -weichen, sowie verfahren zu seiner herstellung
DE3670625D1 (de) Pressgeformter zementkoerper mit glasfaserverstaerkung und verfahren zu seiner herstellung.
UA37199C2 (uk) Алкіламінокетони
AT389065B (de) Verfahren zur herstellung eines brenners, insbesondere gasbrenners sowie nach diesem verfahren hergestellter brenner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition